Rainmed Medical Ltd., a company listed on the main board of the Hong Kong Stock Exchange, has announced a subscription of new shares under a general mandate. The company has entered into a subscription agreement with Apsara Technology Limited, an independent third party, for the issuance of 233,559,800 new ordinary shares at a subscription price of HK$0.163 per share. This transaction is subject to the fulfillment of certain conditions outlined in the agreement. Shareholders and potential subscribers are advised to exercise caution when dealing with the company's shares.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。